| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| 01/2/2020 |
Director
Trans History: 207
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $41.45 | 40,372 |
| 12/31/2019 |
Director
Trans History: 67
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 413 | $41.59 | 12,387 |
| 12/31/2019 |
Director
Trans History: 35
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 356 | $41.59 | 2,824 |
| 12/31/2019 |
Director
Trans History: 49
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 375 | $41.59 | 11,155 |
| 12/31/2019 |
Director
Trans History: 88
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 356 | $41.59 | 27,276 |
| 12/31/2019 |
Director
Trans History: 40
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 356 | $41.59 | 959 |
| 12/31/2019 |
Director
Trans History: 178
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 356 | $41.59 | 40,049 |
| 12/31/2019 |
Chief Risk Officer
Trans History: 120
|
Chief Risk Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10 | $33.94 | 12,949 |
| 12/31/2019 |
Director
Trans History: 29
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 356 | $41.59 | 8,889 |
| 12/31/2019 |
Director
Trans History: 127
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 544 | $41.59 | 44,134 |
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.